Central District Grants Final Approval to Injunctive Relief Settlement in Qunol CoQ10 Liquid Labeling Litigation
On March 13, 2013, Judge David O. Carter granted final approval to a class action based on claims that Defendants mislabeled their “Qunol” product as “six times more effective” than other similar products. Bruno v. Quten Research Institute, LLC, et al. (In re Qunol CoQ10 Liquid Labeling Litigation), No. SACV 11–00173 DOC (Ex), 2013 WL 990495 (C.D. Cal. March 13, 2013) (slip op.).
All excluding officers, directors, and employees of Quten Research Institute, LLC or Tishcon Corp. and their immediate families, who on or after January 31, 2007 purchased Qunol CoQ10 in the United States for personal or household uses, rather than resale or distribution, in packaging stating that Qunol offers six times better absorption or effectiveness. Read the rest of this entry »